News

London-listed AstraZeneca, known for its treatments for cancer, diabetes, and Covid-19, will invest $50 billion in U.S.
In an exclusive interview with Newsweek, the former Commerce Secretary discusses trade, China and tariffs under Trump 2.0.
The Brazil Tariff will result in a significant, and perhaps prohibitive, price increase in a staple American breakfast food," ...
The stock is down, but the reaction is nothing like what happened in April. That’s a positive for investors.
Trade, production, growth and other global economic vitals are proving resilient almost four months after President Trump’s ...
The construction market in the United States is expected to be the most impacted by tariff policies and will slow throughout ...
An escalatory spiral that leads towards Eurasia's 10% 'trade war' scenario, however, would prompt Brussels to deploy ...
Asian governments are hoping a flurry of last-minute diplomacy will secure them better deals from the White House. Japan’s ...